Replimune Group, Inc. — Director's Dealing 2025

Dec 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2025-12-02

Reporting Person: Patel Sushil (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-02	Common Stock	S	10000	$11.13	Disposed	333576	Direct

Footnotes

F1: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 2, 2025, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.

F2: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 to $11.26. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: Following the sales reported on this Form 4, the reporting person continues to beneficially own 333,576 shares of the Issuer's common stock, including restricted stock units. The reporting person also holds options to acquire an aggregate of 753,750 shares of the Issuer's common stock, 331,353 of which are exercisable as of the date hereof.